Mukanov , K., K. Mukantayev, and P. Tarlykov. “GPR161 RECEPTOR AS A NOVEL TARGET FOR ANTIBODY-BASED IMMUNOTHERAPY OF TRIPLE-NEGATIVE BREAST CANCER”. Eurasian Journal of Applied Biotechnology, no. 1, Jan. 2018, doi:10.11134/btp.1.2018.4.